Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values

Rafael Correa-Rocha1, Alicia Pérez, Raquel Lorente

  • 1Laboratorio de Inmunobiología Molecular, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Pediatric Research
|March 9, 2012
PubMed

Insights

Preterm infants have lower immune cell counts, but regulatory T cells (Tregs) are surprisingly higher. This finding may explain leukopenia and guide immune therapies to reduce neonatal mortality.

Area of Science:

  • Neonatal immunology
  • Perinatal health

Background:

  • Neonatal survival has improved, but preterm infants face higher infection risks and mortality.
  • Infections are a major cause of death in preterm neonates.

Purpose of the Study:

  • To investigate the immune status of preterm neonates.
  • To analyze immune cell populations in cord blood from preterm and full-term infants.

Main Methods:

  • Analysis of immune cell frequencies and counts in 211 cord blood samples.
  • Comparison of immune subsets between preterm and full-term neonates.

Main Results:

  • Preterm infants showed lower absolute counts of monocytes, granulocytes, B cells, NK cells, CD4(+), and CD8(+) T cells.
  • Regulatory T cells (Tregs) were the only subset with increased frequency in preterm infants.
  • Decreased plasma levels of interleukin-7 (IL-7) and its receptor frequency were observed in preterm infants.

Conclusions:

  • The elevated frequency of Tregs in preterm infants may contribute to observed leukopenia.
  • Findings suggest potential targets for immune therapies to reduce preterm infant mortality.
  • Further research into IL-7 pathways could inform therapeutic strategies.
Abstract

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...